EVENTS | VIEW CALENDAR
PerkinElmer announces collaboration with Rutgers University
WALTHAM, Mass.—With what is reportedly the largest cell and DNA biobank in the United States, Rutgers University has turned to PerkinElmer Inc. to adopt its technologies for next-generation sequencing (NGS) sample preparation.
The workload is nothing modest—the Rutgers University Cell and DNA Repository (RUCDR) needs the technology to perform quality control on 25,000 DNA samples per week and to enable greater used of large-scale sequencing studies through more efficient automation. According to the two parties, "the combination of PerkinElmer's sample library automation with Rutgers' world-renowned biorepository will make millions of biological samples accessible to researchers worldwide, to help enable large-scale genomic and disease-related studies."
In addition to helping with quality control on a 25,000 sample a week, PerkinElmer's technology will be used to prepare hundreds of DNA and RNA sequence libraries per week, using the Sciclone NGS Workstation, LabChip GX Nucleic Acid Separations System, LabChip DS Microplate Reader and Twister II Microplate Handler.
"Going forward, the RUCDR will have the capacity to prepare every biological sample coming into the repository for automated sequencing applications. This will help expedite research projects, ensure comparable data quality across analytical centers and facilitate large-scale access and use of clinically-relevant samples across a variety of NIH, foundation and industry funded projects," said Dr. Andrew Brooks, associate professor of genetics and chief operating officer of the Rutgers University Cell and DNA Repository, in the news release about the deal. "As preserving prepared libraries of patient samples is becoming a new standard practice for accelerating NGS studies, it is our intention to continue to be the leader in providing researchers with unparalleled access to high quality nucleic acid and cellular material to make potential therapies and diagnostics more powerful and accurate. Without this critical relationship with PerkinElmer, we would not have been able to achieve these goals as efficiently as we have."
"Dr. Brooks was an early adopter of the Labchip DNA separation technology, and more recently a contributor to the development, and early adopter of, the Labchip DS microfluidic absorbance reader for nucleic acid quantitation and purity," Andrew Barry, product marketing manager at PerkinElmer, tells ddn. "This identified Dr. Brooks as someone who, as a customer, could add significant value to product development, and as a pioneer in his field, someone who could really help guide us through questions that we, as an industrial partner face on a daily basis."
When Dr. Brooks was looking to add NGS capabilities to his biorepository workflows, the opportunity to work together using the Sciclone NGS automation platform was apparent, Barry says, adding, "More than anything, the relationship highlights the emphasis and value that Caliper, and now PerkinElmer, place on working closely with partners in academia to develop technologies that are enabling for customers."